BioSpace News Archive

Business

Pfizer Bets $2.26 Billion on Trillium’s Checkpoint Inhibitors

Under the terms of the deal, Pfizer is picking up all outstanding shares of Trillium that it doesn’t already own for $18.50 per share in cash.

August 23, 2021
·
3 min read
·
Mark Terry
Business

Genevant, Takeda Enter Collab to Find a Cure for Rare Liver Diseases

Genevant Sciences has announced a collaboration deal with Takeda Pharmaceutical to create and commercialize new therapies to treat two undisclosed types of rare liver diseases.

August 23, 2021
·
2 min read
·
Vanessa Doctor, RN
Business

Prominent Whitehead Institute Cell Biologist Terminated for Sexual Harassment

David Sabatini had initially been suspended from his position, but following the conclusion of the investigation, he was terminated over the weekend.

August 23, 2021
·
2 min read
·
Alex Keown
Biotech Beach

Oral Remdesivir Could Lower COVID Hospitalizations, Preclinical Study Says

An oral version of remdesivir is being developed by scientists at the University of California San Diego to combat the SARS-CoV-2 virus early in its infection cycle.

August 23, 2021
·
3 min read
·
Gail Dutton
Drug Development

Starpharma’s Nasal Spray Reduces SARS-CoV-2 by Over 99.9% in Animal Studies

Starpharma’s Viraleze has reduced the viral load by over 99.9% when it was administered nasally into the trachea and lungs of animals who were positive with the virus, compared to saline control.

August 23, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Pondering a Potential Link Between COVID-19 and Alzheimer’s Disease

Research presented earlier this month discussed a possible link between COVID-19 and long-term cognitive deficits and how it may accelerate the pathology and symptoms of Alzheimer’s disease.

August 23, 2021
·
4 min read
·
Mark Terry
Policy

FDA Says “Stop It” to Self-Medicating for COVID-19 with Unapproved Treatments

“You are not a horse. You are not a cow. Seriously, y’all. Stop it.” This is the FDA’s recently tweeted advice to Americans seeking out alternative, unapproved treatments for COVID-19.

August 23, 2021
·
2 min read
·
Kate Goodwin
FDA

FDA Fully Approves First COVID-19 Vaccine

Many expect the full approval will lead to vaccine mandates, as that was one of the obstacles to it for many organizations.

August 23, 2021
·
3 min read
·
Mark Terry
Policy

Anti-Aging Foundation Terminates de Grey After Alleged Attempt to Influence Investigation

Anti-aging organization SENS Research Foundation sacked Chief Science Officer Aubrey de Grey over concerns he has attempted to influence an investigation of sexual harassment claims filed against him.

August 23, 2021
·
2 min read
·
Alex Keown
Drug Development

COVID-19 Booster Shots, the Flu and You

While last flu season saw fears of a “twindemic” go largely unfounded, there are fears that recent lockdowns could also lead to a lack of natural immunity against the flu.

August 23, 2021
·
2 min read
·
Heather McKenzie